Press News

Press News

Press News | 24.06.2026

Print:
Title Media Publ. Date
Mergers and acquisitions as a driver of competitiveness Kathimerini 24/06/2026
Lilly wants to become the Apple of pharmaceutical companies Kathimerini 24/06/2026
Three hospitals from the future Kathimerini 24/06/2026
Bank of Greece – Monetary policy report: Transforming the economy through 16 initiatives Naftemporiki 24/06/2026
VIANEX: Official launch of the new Research and Trials Center Naftemporiki 24/06/2026
Financial ties Ta Nea 24/06/2026
Regarding the cost of the … medicine Ta Nea 24/06/2026
Bank of Greece: Stronger growth, lower inflation Ta Nea 24/06/2026
Ioulia Tseti: We have strategically chosen to invest in medicines that support longevity Farmakeutikos Kosmos 01/04/2026

 

See here the publicity

 

Web Monitoring Report for the period 23/06 – 24/06

Title Media Publ. Date
Akis Skertsos: And yet, the economy’s productive model is changing amna.gr 23/06/2026
EOPYY: Launches a sweeping audit campaign targeting prescriptions, diagnostic tests, and billing practices by private healthcare providers ethnos.gr 24/06/2026
Stefan Oelrich: Europe must reconsider how it prices new medicines healthdaily.gr 24/06/2026
MoH: New bill to introduce free access to personal health data – What it will mean for prescriptions, hospital stays, and medical examinations healthreport.gr 24/06/2026
HTA Committee at a standstill – Dozens of pharmaceutical dossiers await review as meetings cannot be held healthview.gr 23/06/2026
An additional €200 million by 2029 iatronet.gr 24/06/2026
Europe’s competitive edge in pharmaceutical sector lies in its excellence in basic research and strong production capacity in.gr 24/06/2026
Plasma collection: Why is it important for Europe to have self-sufficiency, and what is Greece’s position? lifo.gr 23/06/2026
D. Giannakopoulos: What the new VIANEX investment in Patras means for the company’s future mononews.gr 24/06/2026
Boukovinas: The future of oncology lies in combination therapies and AI news247.gr 23/06/2026
Eli Lilly: Trump’s pricing policy will affect the launch of obesity medicines in Europe news4health.gr 24/06/2026
HeSMO: Symposium on the health economics of cancer, innovation, access to care, and sustainability news4health.gr 23/06/2026
These medicines were originally designed for other conditions – 3 stories that transformed men’s health protothema.gr 24/06/2026
Clawback: €1.1 billion to be imposed on pharmaceutical companies in 2025 protothema.gr 23/06/2026

RELATED NEWS

Skip to content